Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Banting Postdoctoral Fellowship Program

Direct Payment

$140,000.00

Gamma delta T cell ligands in multiple sclerosis

FY 2023-24

Summary
T cells, a type of white blood cells, play a crucial role in the defense against infections. However, they can also attack healthy organs and cause inflammation. Multiple sclerosis is a disease where the immune system attacks the brain and spinal cord, and T cells play a significant role. An understudied type of T cells called gamma delta T cells have been associated with multiple sclerosis (MS). However, there is still limited understanding of the role these cells play in MS. Our research aims to understand how those cells can cause inflammation. First, we will investigate a virus called Epstein-Barr virus (EBV). This virus was recently linked to MS. We hypothesize that EBV may cause inflammation by activating these gamma delta T cells, which then go on to cause inflammation. Second, we will investigate a protein called myelin oligodendrocyte glycoprotein (MOG), which is present on nerve cells. The structure of the protein is very similar to other gamma delta T cell triggers. We hypothesize that MOG may also activate gamma delta T cells and cause inflammation. To answer those two questions, we will study blood samples from MS patients and compare them to healthy individuals. We will expose these samples to both the virus and the MOG protein to see if there's a reaction, especially from the gamma delta T cells. This will help us determine if these factors are indeed playing a role in activating these cells and, by extension, their involvement in MS. Understanding these interactions has potential implications not only for MS but also for our broader understanding of immune system disorders. If we can pinpoint what's setting off these gamma delta T cells, we can develop treatments that prevent or limit their activation, offering a new approach to treating MS and other autoimmune diseases.
Program
Banting Postdoctoral Fellowship Program
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
491819
Name
Bilodeau Philippe-Antoine
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Gamma delta T cell ligands in multiple sclerosis
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Epstein-Barr Virus; Gamma Delta T Cells; Multiple Sclerosis; Myelin Oligodendrocyte Glycoprotein; T Cell Receptor
Abstract
T cells, a type of white blood cells, play a crucial role in the defense against infections. However, they can also attack healthy organs and cause inflammation. Multiple sclerosis is a disease where the immune system attacks the brain and spinal cord, and T cells play a significant role. An understudied type of T cells called gamma delta T cells have been associated with multiple sclerosis (MS). However, there is still limited understanding of the role these cells play in MS. Our research aims to understand how those cells can cause inflammation. First, we will investigate a virus called Epstein-Barr virus (EBV). This virus was recently linked to MS. We hypothesize that EBV may cause inflammation by activating these gamma delta T cells, which then go on to cause inflammation. Second, we will investigate a protein called myelin oligodendrocyte glycoprotein (MOG), which is present on nerve cells. The structure of the protein is very similar to other gamma delta T cell triggers. We hypothesize that MOG may also activate gamma delta T cells and cause inflammation. To answer those two questions, we will study blood samples from MS patients and compare them to healthy individuals. We will expose these samples to both the virus and the MOG protein to see if there's a reaction, especially from the gamma delta T cells. This will help us determine if these factors are indeed playing a role in activating these cells and, by extension, their involvement in MS. Understanding these interactions has potential implications not only for MS but also for our broader understanding of immune system disorders. If we can pinpoint what's setting off these gamma delta T cells, we can develop treatments that prevent or limit their activation, offering a new approach to treating MS and other autoimmune diseases.
Competitiondate
202309
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Bilodeau, Philippe-Antoine
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~
Direct Payment - $140,000 Grant (2023-24) | Canada Spends